Decision Diagnostics (DECN) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 130 sessions, January 16, 2024 to January 16, 2025
- Largest daily move
- +0% close of January 17, 2024
Company Description
Decision Diagnostics (OTC: DECN) is classified in the pharmaceutical retailers industry within the Healthcare sector and carries a market capitalization of $35.8K.
This page collects what Stock Titan holds for DECN, including price data, latest news, and short interest trends.
Stock Performance
Decision Diagnostics (DECN) closed at $0.0001 on January 16, 2025.
DECN Metrics & Rankings
Price returns through January 16, 2025. Ranking links may use different dates.
Latest News
Decision Diagnostics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include covid-19, fda approval. View all DECN news →
SEC Filings
Short Interest History
Short interest in Decision Diagnostics (DECN) currently stands at 100 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for Decision Diagnostics (DECN) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
DECN Company Profile & Sector Positioning
Decision Diagnostics (DECN) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing DECN often look at related companies in the same sector, including Pineapple Inc (PNPL), Allstar Hlth Brands Inc (ALST), Health Advance Inc (HADV), Scientist Home FTR Hlth (SHFH), and Polomar Health Svcs Inc (PMHS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DECN's relative position within its industry.